Enliven Therapeutics, Inc.
ELVNFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Enliven Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Patient Square Capital LP | 2026-03-31 | 200,000 | $7.84M | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 345,318 | $13.5M | SEC filing |
| DIADEMA PARTNERS LP | 2026-03-31 | 245 | $9.6K | SEC filing |
| SPHERA FUNDS MANAGEMENT LTD. | 2026-03-31 | 153,265 | $6.01M | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 1,575 | $61.7K | SEC filing |
| PRELUDE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 52,578 | $2.06M | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 3,096 | $121K | SEC filing |
| Brevan Howard Capital Management LP | 2026-03-31 | 22,232 | $871K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 11,162 | $438K | SEC filing |
| Affinity Asset Advisors, LLC | 2026-03-31 | 586,904 | $23M | SEC filing |
| STEMPOINT CAPITAL LP | 2026-03-31 | 363,438 | $14.2M | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 22,094 | $866K | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 38,323 | $1.5M | SEC filing |
| MassMutual Private Wealth & Trust, FSB | 2026-03-31 | 208 | $8.15K | SEC filing |
| PRUDENTIAL FINANCIAL INC | 2026-03-31 | 66,940 | $2.62M | SEC filing |
| FRANKLIN RESOURCES INC | 2026-03-31 | 20,182 | $791K | SEC filing |
| Swiss National Bank | 2026-03-31 | 64,273 | $2.52M | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 11,830 | $464K | SEC filing |
| Brooklyn Investment Group | 2026-03-31 | 11,660 | $457K | SEC filing |
| NOMURA ASSET MANAGEMENT CO LTD | 2026-03-31 | 0 | $0 | SEC filing |
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-22 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −24,846 | 45.38 | SEC filing |
| 2026-06-22 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −1,477 | 45.00 | SEC filing |
| 2026-06-22 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −46,776 | 45.00 | SEC filing |
| 2026-06-22 | ORBIMED ADVISORS LLC · 10% owner | Common Stock | S — Open market or private sale | −787,024 | 45.38 | SEC filing |
| 2026-06-17 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −1,133 | 44.74 | SEC filing |
| 2026-06-17 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −3,401 | 43.86 | SEC filing |
| 2026-06-17 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Common Stock | S — Open market or private sale | −2,599 | 43.87 | SEC filing |
| 2026-06-17 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −1,238 | 44.75 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
| 2026-06-17 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Common Stock | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-06-17 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −6,018 | SEC filing |
| 2026-06-17 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Common Stock | M — Exercise or conversion of derivative security | +6,018 | SEC filing |
| 2026-05-18 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
| 2026-05-18 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Common Stock | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-04-17 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Common Stock | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-04-17 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.